vs
Side-by-side financial comparison of Citi Trends Inc (CTRN) and AMICUS THERAPEUTICS, INC. (FOLD). Click either name above to swap in a different company.
Citi Trends Inc is the larger business by last-quarter revenue ($197.1M vs $185.2M, roughly 1.1× AMICUS THERAPEUTICS, INC.). AMICUS THERAPEUTICS, INC. runs the higher net margin — 0.9% vs -3.5%, a 4.4% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs 10.1%). AMICUS THERAPEUTICS, INC. produced more free cash flow last quarter ($16.0M vs $767.0K). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs -4.3%).
Citi Trends, Inc. is an American retail clothing chain selling discounted products targeted primarily at African-American customers.
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
CTRN vs FOLD — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $197.1M | $185.2M |
| Net Profit | $-6.9M | $1.7M |
| Gross Margin | — | 85.7% |
| Operating Margin | -3.7% | 8.6% |
| Net Margin | -3.5% | 0.9% |
| Revenue YoY | 10.1% | 23.7% |
| Net Profit YoY | 3.6% | -88.5% |
| EPS (diluted) | $-0.86 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $197.1M | $185.2M | ||
| Q3 25 | $190.8M | $169.1M | ||
| Q2 25 | $201.7M | $154.7M | ||
| Q1 25 | $211.2M | $125.2M | ||
| Q4 24 | $179.1M | $149.7M | ||
| Q3 24 | $176.6M | $141.5M | ||
| Q2 24 | $186.3M | $126.7M | ||
| Q1 24 | $215.2M | $110.4M |
| Q4 25 | $-6.9M | $1.7M | ||
| Q3 25 | $3.8M | $17.3M | ||
| Q2 25 | $871.0K | $-24.4M | ||
| Q1 25 | $-14.2M | $-21.7M | ||
| Q4 24 | $-7.2M | $14.7M | ||
| Q3 24 | $-18.4M | $-6.7M | ||
| Q2 24 | $-3.4M | $-15.7M | ||
| Q1 24 | $3.6M | $-48.4M |
| Q4 25 | — | 85.7% | ||
| Q3 25 | — | 88.5% | ||
| Q2 25 | — | 90.2% | ||
| Q1 25 | — | 90.7% | ||
| Q4 24 | — | 90.1% | ||
| Q3 24 | — | 90.6% | ||
| Q2 24 | — | 91.1% | ||
| Q1 24 | — | 87.7% |
| Q4 25 | -3.7% | 8.6% | ||
| Q3 25 | 1.8% | 20.3% | ||
| Q2 25 | 0.2% | -6.1% | ||
| Q1 25 | 0.6% | -6.3% | ||
| Q4 24 | -4.9% | 10.7% | ||
| Q3 24 | -14.1% | 15.3% | ||
| Q2 24 | -3.7% | 11.8% | ||
| Q1 24 | 1.8% | -25.1% |
| Q4 25 | -3.5% | 0.9% | ||
| Q3 25 | 2.0% | 10.2% | ||
| Q2 25 | 0.4% | -15.8% | ||
| Q1 25 | -6.7% | -17.3% | ||
| Q4 24 | -4.0% | 9.8% | ||
| Q3 24 | -10.4% | -4.8% | ||
| Q2 24 | -1.8% | -12.4% | ||
| Q1 24 | 1.7% | -43.9% |
| Q4 25 | $-0.86 | $0.00 | ||
| Q3 25 | $0.46 | $0.06 | ||
| Q2 25 | $0.11 | $-0.08 | ||
| Q1 25 | $-1.70 | $-0.07 | ||
| Q4 24 | $-0.86 | $0.05 | ||
| Q3 24 | $-2.21 | $-0.02 | ||
| Q2 24 | $-0.42 | $-0.05 | ||
| Q1 24 | $0.43 | $-0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $293.5M |
| Total DebtLower is stronger | — | $392.7M |
| Stockholders' EquityBook value | $107.8M | $274.2M |
| Total Assets | $464.3M | $949.9M |
| Debt / EquityLower = less leverage | — | 1.43× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $293.5M | ||
| Q3 25 | — | $263.8M | ||
| Q2 25 | — | $231.0M | ||
| Q1 25 | — | $250.6M | ||
| Q4 24 | — | $249.9M | ||
| Q3 24 | — | $249.8M | ||
| Q2 24 | — | $260.1M | ||
| Q1 24 | — | $239.6M |
| Q4 25 | — | $392.7M | ||
| Q3 25 | — | $392.0M | ||
| Q2 25 | — | $391.3M | ||
| Q1 25 | — | $390.7M | ||
| Q4 24 | — | $390.1M | ||
| Q3 24 | — | $389.5M | ||
| Q2 24 | — | $388.9M | ||
| Q1 24 | — | $388.4M |
| Q4 25 | $107.8M | $274.2M | ||
| Q3 25 | $113.2M | $230.4M | ||
| Q2 25 | $108.6M | $204.3M | ||
| Q1 25 | $113.2M | $193.6M | ||
| Q4 24 | $130.3M | $194.0M | ||
| Q3 24 | $136.6M | $178.8M | ||
| Q2 24 | $154.8M | $132.5M | ||
| Q1 24 | $157.7M | $130.7M |
| Q4 25 | $464.3M | $949.9M | ||
| Q3 25 | $457.4M | $868.8M | ||
| Q2 25 | $437.4M | $815.3M | ||
| Q1 25 | $462.8M | $789.8M | ||
| Q4 24 | $467.1M | $785.0M | ||
| Q3 24 | $506.7M | $786.6M | ||
| Q2 24 | $484.1M | $749.5M | ||
| Q1 24 | $518.7M | $721.8M |
| Q4 25 | — | 1.43× | ||
| Q3 25 | — | 1.70× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.02× | ||
| Q4 24 | — | 2.01× | ||
| Q3 24 | — | 2.18× | ||
| Q2 24 | — | 2.93× | ||
| Q1 24 | — | 2.97× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.6M | $16.3M |
| Free Cash FlowOCF − Capex | $767.0K | $16.0M |
| FCF MarginFCF / Revenue | 0.4% | 8.6% |
| Capex IntensityCapex / Revenue | 4.0% | 0.2% |
| Cash ConversionOCF / Net Profit | — | 9.62× |
| TTM Free Cash FlowTrailing 4 quarters | $11.9M | $29.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.6M | $16.3M | ||
| Q3 25 | $3.9M | $35.7M | ||
| Q2 25 | $-11.0M | $-26.5M | ||
| Q1 25 | $28.5M | $7.8M | ||
| Q4 24 | $-18.4M | $-3.9M | ||
| Q3 24 | $5.6M | $-23.0M | ||
| Q2 24 | $-19.6M | $22.7M | ||
| Q1 24 | $23.3M | $-29.7M |
| Q4 25 | $767.0K | $16.0M | ||
| Q3 25 | $-1.7M | $35.3M | ||
| Q2 25 | $-13.1M | $-28.9M | ||
| Q1 25 | $26.0M | $7.5M | ||
| Q4 24 | $-20.4M | $-4.2M | ||
| Q3 24 | $1.7M | $-23.3M | ||
| Q2 24 | $-21.2M | $21.6M | ||
| Q1 24 | $20.0M | $-31.5M |
| Q4 25 | 0.4% | 8.6% | ||
| Q3 25 | -0.9% | 20.9% | ||
| Q2 25 | -6.5% | -18.7% | ||
| Q1 25 | 12.3% | 6.0% | ||
| Q4 24 | -11.4% | -2.8% | ||
| Q3 24 | 0.9% | -16.5% | ||
| Q2 24 | -11.4% | 17.0% | ||
| Q1 24 | 9.3% | -28.5% |
| Q4 25 | 4.0% | 0.2% | ||
| Q3 25 | 2.9% | 0.2% | ||
| Q2 25 | 1.0% | 1.6% | ||
| Q1 25 | 1.2% | 0.2% | ||
| Q4 24 | 1.1% | 0.2% | ||
| Q3 24 | 2.2% | 0.3% | ||
| Q2 24 | 0.9% | 0.9% | ||
| Q1 24 | 1.5% | 1.6% |
| Q4 25 | — | 9.62× | ||
| Q3 25 | 1.01× | 2.06× | ||
| Q2 25 | -12.59× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 6.56× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTRN
Segment breakdown not available.
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
